Tag Archive for: Florencia Fernandez

RC Law Advised Insud Pharma on its Acquisition of Agile Therapeutics

 

RC Law LLP is proud to have advised Insud Pharma S.L., a global pharmaceutical group based in Spain, on its acquisition of Agile Therapeutics, Inc (OTCOB, AGRX) through the merger of the target company with one of the client’s US subsidiaries, as reported by Nasdaq on August 26, 2024. Loeb & Loeb LLP acted as co-counsel for Insud Pharma and the target and its shareholders were advised by Morgan, Lewis & Bockius LLP.

Source: https://www.nasdaq.com/press-release/agile-therapeutics-inc-announces-completion-acquisition-insud-pharma-sl-2024-08-26https://lnkd.in/eQCbEBx2

 

 

RC Law Advised Mediktor on the Acquisition of Sensely

RC Law advised Teckel Medical S.L. (known as Mediktor) on the acquisition of Sensely, a California-based digital healthcare provider. Mediktor is a leading digital healthcare provider and as a result of the merger, one of the largest global AI-based solution providers in the healthcare ecosystem has been created.  RC Law acted as co-counsel, jointly with Baker & Mckenzie Spain.  Sensely was represented by Perkins Coie, California. RC Law’s team was led by Partner Xavier Ruiz and supported by Associates Diego Price, Florencia Fernandez and Carla Marco. Partner Marta Garcia advised on employment matters.  Mediktor is a long-standing client of the firm.


BARCELONA, ESP. and SAN FRANCISCO, CA. June 4th 2024 — Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a major medical technology milestone, extending Mediktor’s global presence to more than 35 countries and expanding its footprint in the United States.

The merger creates one of the largest global AI-based solutions providers in the healthcare ecosystem. The new organization will be driven by an enriched conversational healthcare platform to help increase efficiencies and reduce costs using its complementary technologies, including the company’s AI medical assistant. According to a recent survey of insurance customers, 54% of patients who used it were satisfied with the medical guidance it provided and did not need additional services or follow-up from a physician. 

“This acquisition is a transformational step for Mediktor and reinforces our commitment to digital health innovation. By joining forces with Sensely, we are poised to offer a leading top-notch AI solution to multiple businesses, ultimately improving millions of people’s access to healthcare,” states Cristian Pascual, Chief Executive Officer of Mediktor.

As a result of the integration, Mediktor will acquire educational healthcare content from Mayo Clinic, which was developed as part of a pre-existing agreement with Sensely. Mayo Clinic will also become a shareholder of the newly integrated company and hold a seat on the Board of Directors as an observer. 

MTIP, a leading Swiss-based growth equity firm and long-standing partner of Mediktor, has reaffirmed its confidence in the company’s vision and direction. As a member of the Mediktor Board of Directors,  MTIP has communicated its unwavering financial and strategic support of the company’s acquisition of Sensely and its overall growth strategy. 

At the same time, Aliath Bioventures, a venture capital firm that has been supporting Mediktor since 2018, also played a significant role in facilitating this acquisition. Aliath remains deeply committed to supporting Mediktor’s strategic growth, strengthening its market leadership, and long-term success.

“Mediktor and Sensely represent the perfect synergy between AI-based symptom assessment and empathy-driven virtual assistance that puts patients at the center,” said Adam Odessky, Sensely’s Co-Founder and CEO. “The combination of these two organizations provides customers with a strong, comprehensive suite of technology services that are proven to increase efficiency and reduce overhead costs for institutions while offering unparalleled personalized engagement services to patients and insurance members. We’re excited to share Mediktor’s vision for becoming a leading player in an evolving and competitive digital healthcare environment.”   

Mediktor plans to integrate Sensely’s current staff and management team into the new organization, where Mr. Odessky will take on the role of Chief Product Officer, bringing his vast experience and leadership to the team. 

About Mediktor

Mediktor is the most advanced AI-based medical chatbot for triage and pre-diagnosis that guides patients to the right level of care at the right time – improving access while enabling more efficient care navigation. Powered by a sophisticated AI engine that enables users to converse naturally in several languages, Mediktor’s white-labeled SaaS is omnichannel and can be easily embedded into any interface (web, mobile, desktop). Mediktor’s customers include health plans, hospitals and health systems, telehealth, and pharmaceutical companies. For more information, please visit www.mediktor.com

About Sensely

Sensely is a leading innovator of avatar and chatbot-based platforms that are designed to assist insurance plan members and patients with the insurance services and healthcare resources whenever they need them. With offices in San Francisco and London, Sensely’s global teams provide virtual assistant solutions to an array of diversified healthcare sectors, including insurance companies, hospital systems, and pharmaceutical clients worldwide. For more information, visit www.sensely.com.

About MTIP

MTIP is a Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare. The team leverages deep sector expertise to help scale up successful and sustainable healthtech businesses For more information, visit www.mtip.ch.

About Aliath Bioventures

Aliath Bioventures, formerly known as Alta Life Sciences, is a life sciences venture capital firm part of the AltamarCAM group. Aliath aims to provide solutions to the most pressing healthcare challenges by targeting therapeutics and healthtech companies built on innovative and disruptive trends. For more information visit https://www.aliathbio.com/.

Source: https://www.mediktor.com/en-us/news/press/mediktor-acquires-sensely-and-consolidates-its-position-as-a-leader-in-ai-healthcare-solutions

 

RC Law Acted on KCE’s US Sell to an Asian Private Equity Firm


Press Release by CTL Pack

KCE, OWNER OF CTLPACK GROUP, SELLS USA SUBSIDIARY TO ICONS GROUP AND TRANSFERS MANUFACTURING ACTIVITIES FROM BARCELONA TO CTLPACK VITORIA

KAIZAHARRA CORPORACION EMPRESARIAL (KCE), owner of the CTLpack Group (formerly TUBOPLAST), has closed an agreement for the sale of 100% of the capital of its subsidiary CTLpack USA, located in Charlotte (North Carolina) to the ICONS Group. The agreement, finalized this week, includes the collaboration of the CTLpack Group to continue supplying components for the manufacture of cosmetic tubes, as well as technical assistance services.

The closure of CTLpack Barcelona (formerly TAPSER) took place on July 31, 2023, transferring the laminated tube manufacturing facilities to CTLpack’s plant in Vitoria. This transfer has already been carried out, and the manufacturing of laminated tubes at the Vitoria plant is now operational.

Both operations, the transfer of CTLpack Barcelona and the sale of CTLpack USA, in addition to the development of the investment and modernization plan that is in execution period, are part of KCE’s strategy to strengthen the position of CTLpack Group as one of the leading companies in Europe in cosmetic and pharmaceutical tube packaging. In this way, the design and technology capabilities of the Vitoria plant will be strengthened and the manufacturing capabilities of the Vitoria and Vichy – France plants will be modernized.

Source: https://ctlpack.com/en/kce-owner-of-ctlpack-group-sells-usa-subsidiary-to-icons-group-and-transfers-manufacturing-activities-from-barcelona-to-ctlpack-vitoria/


Press Release by ICONS USA

ICONS BEAUTY GROUP ACQUIRES ON-SHORE USA PACKAGING MANUFACTURER

ICONS Beauty Group (“ICONS”) a cosmetic, beauty and health group of companies, and a ShawKwei & Partners portfolio company, announces the 100% acquisition of CTL Packaging USA, Inc. (“CTL”).  CTL will now operate as ICONS America LLC.  The facility specializes in the production of injection molded tubes using In-Molded Label (“IML”) technology for the beauty and health industry, providing high-quality decorative capabilities and luxury finishing.

Based in Charlotte, North Carolina, CTL was founded in 2011 as part of CTLpack Group S.L.U., a long-standing Spanish tube manufacturer for beauty and health products.  The facility will merge into ICONS Beauty Group, which is headquartered in Singapore, to broaden its capabilities with made-in-USA quality products.  ICONS has an over 30-year history of providing beauty and health customers with quality packaging products such as tubes, bottles, jars and accessories. Recently, ICONS has started production of sustainable rigid packaging products from its group factory in Thailand bringing more diversity to the supply chain.  In addition, ICONS has a factory in Sydney, Australia producing natural and innovative hair treatments, personal care and skincare for specialty brands in Australia, USA and Europe.

Sue Nichols, the CEO of ICONS Group, said, “CTL has an experienced management team with well-established technology and proven products already in the market. We welcome CTL to the ICONS family as ICONS America LLC. The acquisition provides customers with a USA onshore manufacturing solution which reduces the carbon footprint by manufacturing close to their customers and shortening the shipment delivery lead time.  We look forward to delivering a broad selection of innovative and cost-efficient quality products to our customers.”

Kyle Shaw, Founder and Managing Partner of ShawKwei said, ” The beauty and health industry has a complex value chain, and the combination of CTL with ICONS provides USA customers with greater flexibility to optimize their supply chain and accelerate time-to-market for new products.  ICONS already has a well-developed beauty and health packaging business in Asia and an Australian manufacturer of hair treatments, personal care and skincare. ICONS Beauty Group will leverage their current capabilities together with ICONS America LLC manufacturing operations to expand ICONS packaging products and capabilities.”

About Icons Beauty Group

Icons Beauty Group (“ICONS”) is owned by ShawKwei & Partners and ICONS management and is described more fully at www.iconsbeautygroup.com.  ICONS delivers innovative and sustainable product solutions to beauty and health customers in USA, Europe and Australia. ICONS has two wholly owned subsidiaries with ICONS|ICS and ICONS|Rauxel.   ICONS|ICS is a full-service provider of primary packaging, design and supply to color cosmetic, skincare, pharmaceutical and beauty customers. ICONS|ICS has a global presence with offices in Asia, North America and Australia and a top tier Corporate Social Responsibility rating with a Platinum EcoVadis Medal, SEDEX and UN Global Compact memberships. ICONS|Rauxel is based in Sydney, Australia and is a leading private label manufacturer of premium, clean and creative haircare and skincare products and specializes in botanical and natural extract formulations. ICONS|Rauxel is ISO GMP 22716 and Australian Organic certified.

About ShawKwei & Partners

ShawKwei & Partners is a private equity industrial investor with offices in Singapore, Hong Kong, San Francisco, and Shanghai.  ShawKwei & Partners invests in industrial and service companies with revenues between US$50-800 million operating across Asia, Europe, and the USA.  After investing, ShawKwei & Partners helps improve a business by partnering with management to identify and realize sustainable performance improvements in sales growth, margin expansion, and capital efficiency.

Kyle Shaw established ShawKwei & Partners in 1998 after previously managing Asian private equity funds for the Tudor Investment Group and Security Pacific National Bank.  Past investments include the energy engineering solutions business of the CR3 Group; the beauty and health business of the ICONS Group; the Chinese adhesive tape manufacturer YongLe Tape; the precision engineering manufacturer of plastics, metals and electronics Beyonics; the German designer and manufacturer of capital equipment for PCB’s, solar cells and lithium batteries Schmid Group; and the contract manufacturer of electronics Flex Holdings (previously Flextronics).  For more information please visit: www.shawkwei.com

Source: https://www.ics-world.com/icons-beauty-group-acquires-on-shore-usa-packaging-manufacturer/